New Journal Website is available at: http://www.journalonweb.com/rcm

Published by: Kowsar

Risk Stratification and Anticoagulation in Low-risk Non-valvular Atrial Fibrillation

Arash Arya 1 , *
Author Information
1 Department of Electrophysiology, Heart Centre University of Leipzig, Leipzig, Germany
This article has a relationship commentary-article with this article : Clinical Implications of Recent Trials on Anticoagulation in Patients with Atrial Fibrillation
Article information
  • Research in Cardiovascular Medicine: February 24, 2013, 2 (1); 76-7
  • Published Online: February 24, 2013
  • Article Type: Letter
  • Received: May 10, 2012
  • Revised: May 20, 2012
  • Accepted: May 27, 2012
  • DOI: 10.5812/cardiovascmed.8118

To Cite: Arya A. Risk Stratification and Anticoagulation in Low-risk Non-valvular Atrial Fibrillation, Res Cardiovasc Med. 2013 ;2(1):76-7. doi: 10.5812/cardiovascmed.8118.

Copyright: Copyright © 0, Research in Cardiovascular Medicine. .
Footnotes
References
  • 1. Arya A, Kircher S, Müssigbrodt A, Eitel C, Sommer P, Hindricks G. Clinical Implications of Recent Trials on Anticoagulation in Patients with Atrial Fibrillation. Res Cardiovasc Med. 2012; 1(1): 3-9[DOI]
  • 2. Lane DA, Lip GY. Use of the CHA2DS2-VASc and HAS-BLED Scores to Aid Decision Making for Thromboprophylaxis in Nonvalvular Atrial Fibrillation. Circulation. 2012; 126(7): 860-5[DOI][PubMed]
  • 3. Banerjee A, Lane DA, Torp-Pedersen C, Lip GY. Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a 'real world' atrial fibrillation population: a modelling analysis based on a nationwide cohort study. Thromb Haemost. 2012; 107(3): 584-9[DOI][PubMed]
  • 4. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation * Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 2012; [PubMed]
  • 5. Connolly SJ, Eikelboom J, Joyner C, Diener HC, Hart R, Golitsyn S, et al. Apixaban in patients with atrial fibrillation. N Engl J Med. 2011; 364(9): 806-17[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .